Associated Papers
Tumor-suppressive activities of SA1/STAG2 and effects of PARP impairment during brain development.
Totaro S et al.
Disease Models & Mechanisms, 2026
41502392 (PubMed )
Supplement: dmm-19-052440-TableS1.xlsx › Foglio1
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.
Kuehn JC et al.
Npj Precision Oncology, 2024
39143272 (PubMed )
Supplement: 41698_2024_674_MOESM2_ESM.xlsx › Supplementary_Data_3
Select a paper to view details